Precision Optics Corporation, Inc.: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 15, 2025 and accepted by EDGAR at May 15, 2025, 16:15 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $4.2m | us-gaap:Revenues |
| Revenue | 9 months2024-07-01 to 2025-03-31 | $12.9m | us-gaap:Revenues |
| Cost of revenue | 3 months2025-01-01 to 2025-03-31 | $3.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2024-07-01 to 2025-03-31 | $10.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2025-01-01 to 2025-03-31 | $418.0k | us-gaap:GrossProfit |
| Gross profit | 9 months2024-07-01 to 2025-03-31 | $2.6m | us-gaap:GrossProfit |
| Research and development | 3 months2025-01-01 to 2025-03-31 | $211.2k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2024-07-01 to 2025-03-31 | $929.6k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2025-01-01 to 2025-03-31 | $2.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-07-01 to 2025-03-31 | $5.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2025-01-01 to 2025-03-31 | −$2.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-07-01 to 2025-03-31 | −$4.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $58.5k | us-gaap:InterestExpense |
| Interest expense | 9 months2024-07-01 to 2025-03-31 | $182.4k | us-gaap:InterestExpense |
| Net income | 3 months2025-01-01 to 2025-03-31 | −$2.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-07-01 to 2025-03-31 | −$4.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | −$0.30 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-07-01 to 2025-03-31 | −$0.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | −$0.30 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-07-01 to 2025-03-31 | −$0.67 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 6,917,281 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-07-01 to 2025-03-31 | 6,491,687 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-07-01 to 2025-03-31 | −$3.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2024-07-01 to 2025-03-31 | $181.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2025-03-31 | $2.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-03-31 | $10.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-03-31 | $19.6m | us-gaap:Assets |
| Current liabilities | At period end2025-03-31 | $5.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-03-31 | $6.4m | us-gaap:Liabilities |
| Long-term debt | At period end2025-03-31 | $1.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-03-31 | $576.4k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-03-31 | $13.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001683168-25-003708. Last ingested by Listed: Oct 30, 2026, 16:26 ET. Listed shows no prices and gives no investment advice.